QQ客服 官方微博 反馈留言

	Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial
	Hou, J. L.; Gao, Z. L.; Xie, Q.; Zhang, J. M.; Sheng, J. F.; Cheng, J.; Chen, C. W.; Mao, Q.; Zhao, W.; Ren, H.
刊名	JOURNAL OF VIRAL HEPATITIS
	2015
卷号	22期号:2
关键词	antiviral therapy chronic hepatitis B efficacy tenofovir disoproxil fumarate
ISSN号	1352-0504
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3544902
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Hou, J. L.,Gao, Z. L.,Xie, Q.,et al. Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial[J]. JOURNAL OF VIRAL HEPATITIS,2015,22(2).
APA	Hou, J. L..,Gao, Z. L..,Xie, Q..,Zhang, J. M..,Sheng, J. F..,...&Li, J..(2015).Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial.JOURNAL OF VIRAL HEPATITIS,22(2).
MLA	Hou, J. L.,et al."Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial".JOURNAL OF VIRAL HEPATITIS 22.2(2015).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。